search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Supplements & functional ingredients


of experts from a broad array of disciplines and perspectives. Members of the GCBH met in Washington, DC to address the topic of dietary supplements and brain health for people age 50 and older. Throughout the discussion, experts examined the evidence on whether the consumption of dietary supplements can impact people’s cognitive function as they age. This supplements report summarises the consensus reached by the experts and describes the major points of discussion that led to their recommendations. It also identifies gaps in knowledge about dietary supplements and brain health. The paper is not intended to be a systematic, exhaustive review of all pertinent scientific literature on the topic. Rather, the selected references provided give helpful background material and present a sizable sample of the current evidence underpinning the GCBH consensus in this area.


Supplementing health Dietary supplements or, more commonly, “supplements”, are products taken by mouth that contain a “dietary ingredient”. Dietary ingredients include vitamins, minerals, amino acids, botanicals [including herbs] and enzymes, as well as other substances alone or in combination that can be used to supplement one’s diet. Supplements come in many forms, including pills, capsules, tablets, powders, food bars and liquids. In 2018 an estimated 85,000 types of dietary- supplement products were sold in the US alone, according to the Nutrition Business Journal, with more than $40bn in retail sales in the US and $121bn worldwide. In conjunction with this report, AARP surveyed a representative sample of adults age 18 and older on their use of various dietary supplements.


Among adults age 50 and older, 81% believe that supplements are at least somewhat important for overall health; 69% are currently taking a dietary supplement at least three times a week. The US Government Accountability Office (GAO) recently examined available data and found that memory supplements were a small but growing portion of the overall market for dietary supplements. In the US, sales nearly doubled in value from 2006 to 2015, increasing to $643m in 2015. According to an industry forecast report, brain-health supplements generated $3bn in sales globally in 2016, and that figure is projected to reach $13.8bn by 2023. Given the vast interest people have in maintaining and improving their brain health as they age, the GCBH has no doubt that the use of brain-health supplements – targeted at an increasingly ageing population worldwide – is growing, and large numbers of people are already taking them.


Ingredients Insight / www.ingredients-insight.com


The 2019 AARP Brain Health and Dietary Supplements Survey shows that more than a quarter of Americans age 50 and older are regularly taking supplements for their brain health – 26% of adults take at least one supplement for brain-health reasons. Among adults specifically taking dietary supplements for brain health, 21% report taking dietary supplements to maintain – and 20% report taking them to improve – their brain health. Interestingly, 11% report currently taking a supplement to delay the onset of dementia, and 8% say they take a supplement to reverse dementia. The GCBH document summarises the state of the scientific evidence on whether dietary supplements currently on the market can benefit the brain health of adults, focusing primarily on those over 50. It discusses a broad range of issues pertaining to supplements and cognitive health and examines the evidence relating to vitamin and mineral supplements, focusing primarily on the eight B vitamins, and vitamins D and E. It also discusses other well-known supplement ingredients commonly marketed for brain health including: the omega-3 fatty acids docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha linoleic acid (ALA); fish oil; medium-chain triglycerides (coconut oil); huperzine-A; caffeine; nicotinamide riboside; phosphatidylserine; curcumin; flavanols; coenzyme Q10 (CoQ10); ginkgo biloba; and apoaequorin (derived from jellyfish). These consensus statements and recommendations are based on the GCBH experts’ knowledge of the field and their evaluation of the best available evidence from peer-reviewed, published observational studies and randomised controlled trials in humans, as well as studies conducted in animals designed to help determine the effects of dietary supplements on brain health.


81% AARP 61%


The percentage of people over 55 currently taking a dietary supplement at least five times a week.


AARP


Among adults age 50 and older, the majority believe that supplements are at least


somewhat important for overall health.


“The GCBH believes that more high-quality clinical studies of the safety and efficacy of dietary supplements on brain health outcomes in humans are needed.”


The role of manufacturers The context in which dietary supplements are manufactured and sold also plays an important role in the consensus and the resulting recommendations. Around the world, manufacturers are generally prohibited from selling unsafe ingredients, but there are no known countries that regulate or evaluate dietary supplements for effectiveness before they are permitted to be sold. There is also no global consensus on how these types of products should


41


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96